Study finds apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications
Dec. 21, 2021— by Jill Clendening There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. An estimated 3 million to 6 million persons...
Study defines association of oral anticoagulants and proton pump inhibitors to gastrointestinal bleeding risk
Dec. 4, 2018—A Vanderbilt University Medical Center study published this week in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor (PPI) in combination with an oral anticoagulant.